Global Viscosupplementation Injection Market Growth 2025-2031

Global Viscosupplementation Injection Market Growth 2025-2031

The global Viscosupplementation Injection market size is predicted to grow from US$ 1245 million in 2025 to US$ 1758 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

The viscosupplementation injection market is driven by the rising prevalence of osteoarthritis, particularly among the aging population. As this treatment involves injecting hyaluronic acid into the joints to improve mobility and reduce pain, it offers a non-surgical alternative to managing osteoarthritis symptoms. The growing demand for minimally invasive procedures and the increasing awareness of joint health are also propelling the market forward. Additionally, advancements in injection technology and the development of next-generation viscosupplements are enhancing treatment outcomes, further supporting market growth.

However, the market faces challenges, including the high cost of viscosupplementation procedures, which can limit patient access, especially in developing regions. Moreover, the treatment's effectiveness may vary between patients, with some experiencing limited relief, which can reduce overall patient satisfaction. Competition from alternative treatments, such as corticosteroid injections and joint replacement surgeries, also presents a challenge to the market's expansion. Regulatory hurdles and reimbursement issues may further impact market growth, as insurers may not fully cover these treatments.

North America is the largest consumption place, with a consumption market share nearly 51% in 2023. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 26%. Market competition is intense. Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 43% market share.

LP Information, Inc. (LPI) ' newest research report, the “Viscosupplementation Injection Industry Forecast” looks at past sales and reviews total world Viscosupplementation Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Viscosupplementation Injection sales for 2025 through 2031. With Viscosupplementation Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viscosupplementation Injection industry.

This Insight Report provides a comprehensive analysis of the global Viscosupplementation Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viscosupplementation Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viscosupplementation Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viscosupplementation Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viscosupplementation Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Viscosupplementation Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Single Injection
Three Injection
Five Injection

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

Key Questions Addressed in this Report

What is the 10-year outlook for the global Viscosupplementation Injection market?

What factors are driving Viscosupplementation Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Viscosupplementation Injection market opportunities vary by end market size?

How does Viscosupplementation Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.